|
|
|
| Efficacy of Intermittent Positive Pressure Ventilation Combined with Pulmonary Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome |
| ZHU Daomou, ZHONG Lihua, CHEN Caihua |
| Hainan Women and Children Medical Center, Hainan Haikou 570000, China |
|
|
|
|
Abstract Objective: To explore the efficacy of intermittent positive pressure ventilation (IPPV) combined with pulmonary surfactant (PS) in the treatment of neonatal respiratory distress syndrome (NRDS). Methods: The data of 153 NRDS patients were analyzed retrospectively from December 2017 to December 2019. All the children were treated with IPPV, and the children with PS were included in the study group (n = 82 cases), while those without PS treatment were included in the control group (n=71). The curative effect, related treatment, arterial blood gas analysis indexes before and after treatment, incidence of adverse reactions, and lung function indexes during follow-up were compared between the two groups. Results: The total response rate in the study group was significantly higher than that in the control group (96.34% vs 84.51%) (P<0.05). The oxygen therapy time, ventilation time, treatment costs and hospital stay of the study group were significantly shorter and lower than those of the control group (P<0.05). After treatment, the arterial partial pressure of carbon dioxide (PaCO2), oxygenation index (OI), arterial partial pressure of oxygen (PaO2), and blood oxygen saturation (SpO2) were significantly improved (P<0.05). And the improvement in the study group was significantly greater than that in the control group (P<0.05). The incidence of bronchopulmonary dysplasia was significantly lower in the study group than in the control group (P<0.05). The study group had lower respiratory rate than the control group, and the tidal volume, volume to peak tidal expiratory flow and time to peak were significantly larger and longer than the control group (P<0.05). Conclusion: Applying iPPV combined with PS in the treatment of NRDS can significantly improve the arterial blood gas analysis indexes in children, and shorten the time of treatment, with significant therapeutic effects.
|
|
|
|
|
|
[1] 张永芳,于新桥,廖建华,等.鄂西南地区新生儿急性呼吸窘迫综合征临床流行病学调查[J].中国当代儿科杂志,2020,22(9):942~947.
[2] Li Y,Zhang C,Zhang D.Cesarean section and the risk of neonatal respiratory distress syndrome:a meta-analysis[J].Arch Gynecol Obstet,2019,300(3):503~517.
[3] Chowdhury N,Giles BL,Dell SD.Full-Term neonatal respiratory distress and chronic lung disease[J].Pediatr Ann,2019,48(4):175~181.
[4] McPherson C,Wambach JA.Prevention and treatment of respiratory distress syndrome in preterm neonates[J].Neonatal Netw,2018,37(3):169~177.
[5] Li Y,Wang W,Zhang D.Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome:a meta-analysis[J].Acta Diabetol,2019,56(7):729~740.
[6] 邵肖梅,叶鸿帽,丘小汕.实用新生儿学[M].第4版.北京:人民卫生出版社,2010.230~232.
[7] Sweet DG,Carnielli V,Greisen G,et al.European consensus guidelines on the management of respiratory distress syndrome-2016 update[J].Neonatology,2017,111(2):107~125.
[8] Lee M,Wu K,Yu A,et al.Pulmonary hemorrhage in neonatal respiratory distress syndrome:radiographic evolution,course,complications and long-term clinical outcomes[J].Neonatal Perinatal Med,2019,12(2):161~171.
[9] Willsey GG,Ventrone S,Schutz KC,et al.Pulmonary surfactant promotes virulence gene expression and biofilm formation in klebsiella pneumoniae[J].Infect Immun,2018,86(7):1~18.
[10] 党嘉文,董文斌,雷小平,等.珂立苏联合鼻塞持续气道正压通气治疗新生儿呼吸衰竭的临床研究[J].中国临床药理学杂志,2018,34(9):19~22.
[11] Wolfler A,Piastra M,Amigoni A,et al.A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome:a feasibility study[J].BMC Pediatr,2019,19(1):203~212.
[12] 陈少军,陈全景,周凤霞.肺表面活性物质联合无创正压通气对新生儿呼吸窘迫的疗效观察及对血气指标的影响[J].河北医学,2020,26(3):411~415.
[13] 邢芳华,林毅,胡夏,等.早期与晚期应用肺表面活性物质联合经鼻持续气道正压通气治疗新生儿呼吸窘迫综合征的比较研究[J].现代生物医学进展,2019,19(13):2571~2575. |
|
|
|
2021, Vol. 27 
